Waddell & Reed Financial’s Boston Scientific BSX Stock Holding History

Waddell & Reed Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,748,936	Closed	-$66.8M	–	485
2020 Q3	$66.8M	Buy	1,748,936 +122,060	+8%	+$4.7M	0.16%	164
2020 Q2	$57.1M	Buy	+1,626,876	New	+$58.6M	0.15%	171
2018 Q4	–	Sell	-240,000	Closed	-$9.24M	–	499
2018 Q3	$9.24M	Buy	240,000 +70,000	+41%	+$2.44M	0.02%	440
2018 Q2	$5.56M	Buy	+170,000	New	+$5.13M	0.01%	483
2014 Q3	–	Sell	-13,402,600	Closed	-$171M	–	534
2014 Q2	$171M	Buy	13,402,600 +1,339,500	+11%	+$17.4M	0.25%	110
2014 Q1	$163M	Buy	12,063,100 +859,700	+8%	+$11.3M	0.25%	105
2013 Q4	$135M	Buy	11,203,400 +1,607,600	+17%	+$19M	0.22%	125
2013 Q3	$113M	Buy	9,595,800 +124,200	+1%	+$1.34M	0.21%	120
2013 Q2	$87.8M	Buy	+9,471,600	New	+$80.3M	0.18%	133

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Waddell & Reed Financial's BSX Position: Q4 2020 in Review

Waddell & Reed Financial sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 1,748,936 shares — an estimated $66.8M sold.

Waddell & Reed Financial first reported a position in BSX in Q2 2013 and held it in 9 quarters. The position peaked at $171M in Q2 2014. 865 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

Waddell & Reed Financial reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
Waddell & Reed Financial sold 1,748,936 Boston Scientific shares in Q4 2020, an estimated $66.8M.
Waddell & Reed Financial first reported a position in Boston Scientific in Q2 2013 and held it in 9 quarters.
Waddell & Reed Financial's Boston Scientific position peaked at $171M in Q2 2014.
865 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Waddell & Reed Financial's 13F filing for Q4 2020, filed 12 Feb 2021.